182 related articles for article (PubMed ID: 24397852)
1. Refractory antilaminin γ1 pemphigoid successfully treated with intravenous immunoglobulin and mycophenolate mofetil.
Alloo A; Strazzula L; Rothschild B; Hawryluk E; Levine D; Hoang MP; Koga H; Hashimoto T; Kroshinsky D
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1401-3. PubMed ID: 24397852
[No Abstract] [Full Text] [Related]
2. A case of refractory antilaminin γ1 pemphigoid successfully treated with dexamethasone and mycophenolate mofetil.
Zhiliang L; Xiaodong Z; Peiying J; Suying F; Baoxi W
Int J Dermatol; 2015; 54(5):e194-6. PubMed ID: 25773159
[No Abstract] [Full Text] [Related]
3. [Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Raffin D; Delaplace M; Roussel A; Estève E
Ann Dermatol Venereol; 2013 Dec; 140(12):784-7. PubMed ID: 24315224
[TBL] [Abstract][Full Text] [Related]
4. Treatment of anti-laminin γ1 pemphigoid with mycophenolate mofetil.
Gawaz A; Metzler G; Hertl M; Hashimoto T; Schaller M
J Dtsch Dermatol Ges; 2015 Jul; 13(7):696-7. PubMed ID: 26058852
[No Abstract] [Full Text] [Related]
5. Refractory bullous pemphigoid with fatal outcome in a young patient.
Cruz MJ; Santos P; Morais P; Barreto F; Azevedo F
Int J Dermatol; 2013 May; 52(5):601-2. PubMed ID: 23590375
[No Abstract] [Full Text] [Related]
6. [Anti-p200 pemphigoid: a spectacular response to dapsone].
Munsch C; Prey S; Joly P; Meyer N; Lamant L; Livideanu C; Viraben R; Paul C
Ann Dermatol Venereol; 2011 Nov; 138(11):739-42. PubMed ID: 22078034
[TBL] [Abstract][Full Text] [Related]
7. Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents: marked improvement in depletion of circulating autoantibodies.
Czernik A; Bystryn JC
Arch Dermatol; 2008 May; 144(5):658-61. PubMed ID: 18490594
[TBL] [Abstract][Full Text] [Related]
8. Refractory Pemphigoid with Autoantibodies to Both BP230 and Laminin gamma1.
Ashida H; Hamada T; Hosokawa Y; Hashimoto T; Nishie W; Ishii N; Nakama T; Kanno T; Ikeda M
Acta Derm Venereol; 2019 Nov; 99(12):1172-1173. PubMed ID: 31449311
[No Abstract] [Full Text] [Related]
9. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
[TBL] [Abstract][Full Text] [Related]
10. Bullous pemphigoid treated with mycophenolate mofetil.
Böhm M; Beissert S; Schwarz T; Metze D; Luger T
Lancet; 1997 Feb; 349(9051):541. PubMed ID: 9048797
[No Abstract] [Full Text] [Related]
11. "Half-half" blisters in bullous pemphigoid successfully treated with adjuvant high-dose intravenous immunoglobulin.
Pacheco D; Lopes L; Soares-Almeida L; Marques MS; Filipe P
Acta Dermatovenerol Alp Pannonica Adriat; 2012 Sep; 21(3):59-61. PubMed ID: 23267874
[TBL] [Abstract][Full Text] [Related]
12. Anti-laminin γ1 pemphigoid associated with ulcerative colitis and psoriasis vulgaris showing autoantibodies to laminin γ1, type XVII collagen and laminin-332.
Akasaka E; Nakano H; Korekawa A; Fukui T; Kaneko T; Koga H; Hashimoto T; Sawamura D
Eur J Dermatol; 2015 Apr; 25(2):198-9. PubMed ID: 25787875
[No Abstract] [Full Text] [Related]
13. Infantile bullous pemphigoid successfully treated with intravenous immunoglobulin therapy.
Watanabe T; Hara S; Muto J; Watanabe D; Akiyama M
Clin Exp Dermatol; 2017 Jul; 42(5):576-578. PubMed ID: 28543802
[No Abstract] [Full Text] [Related]
14. Adjuvant therapy of bullous pemphigoid with mycophenolate mofetil: old drug, new use.
Ratnam KV
Singapore Med J; 2001 Oct; 42(10):482-4. PubMed ID: 11874153
[TBL] [Abstract][Full Text] [Related]
15. Successful therapy for bullous pemphigoid with mycophenolate mofetil.
Nousari HC; Griffin WA; Anhalt GJ
J Am Acad Dermatol; 1998 Sep; 39(3):497-8. PubMed ID: 9738791
[No Abstract] [Full Text] [Related]
16. Comparative effectiveness of azathioprine or mycophenolate mofetil as an adjuvant for the treatment of bullous pemphigoid.
Bystryn JC
Arch Dermatol; 2008 Jul; 144(7):946. PubMed ID: 18645153
[No Abstract] [Full Text] [Related]
17. Treatment of pemphigus vulgaris and bullous pemphigoid with mycophenolate mofetil monotherapy.
Grundmann-Kollmann M; Kaskel P; Leiter U; Krähn G; Behrens S; Peter RU; Kerscher M
Arch Dermatol; 1999 Jun; 135(6):724-5. PubMed ID: 10376713
[No Abstract] [Full Text] [Related]
18. Positive clinical outcome in a patient with recalcitrant bullous pemphigoid treated with rituximab and intravenous immunoglobulin.
Nguyen T; Ahmed AR
Clin Exp Dermatol; 2017 Jul; 42(5):516-519. PubMed ID: 28508388
[TBL] [Abstract][Full Text] [Related]
19. Bullous pemphigoid associated with type 1 diabetes mellitus responsive to mycophenolate mofetil.
Sakanoue M; Kawai K; Kanekura T
J Dermatol; 2012 Oct; 39(10):884-5. PubMed ID: 22168231
[No Abstract] [Full Text] [Related]
20. Bullous pemphigoid in late childhood successfully treated with mycophenolate mofetil as an adjuvant therapy.
Fox JC; Kenkare S; Petronic-Rosic V; Soltani K; Sethi A
Pediatr Dermatol; 2010; 27(5):537-9. PubMed ID: 20807355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
